SWEET TRADE TATTOO

LIVE

Serial Number

97735946

Owner

Considine, Athena

Attorney

Joshua M. Gerben, Esq.

Filing Date

Dec 29, 2022

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

SWEET TRADE TATTOO Trademark

Serial Number: 97735946 • Registration: 7297778

SWEET TRADE TATTOO is a trademark filed by Considine, Athena on December 29, 2022. The trademark is classified under Class 44 (Medical Services). The application is currently registered and active.

Trademark Classes

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Owner Contact Info

Considine, Athena (2 trademarks)

3600 Lower Honoapiilani Road B-1
Honoapiilani, HI 96761

Entity Type: 01

Considine, Adam (2 trademarks)

3600 Lower Honoapiilani Road B-1
Lahaina, HI 96761

Entity Type: 01

Legal Representation

Attorney of Record

Joshua M. Gerben, Esq.

9,806 trademarks filed View all →

Trademark Details

Filing Date

December 29, 2022

Registration Date

February 6, 2024

Published for Opposition

November 21, 2023

Goods & Services

Tattooing; Tattoo parlors; Tattoo studios; Tattooing services

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Feb 6, 2024 NRCC

REGISTERED-PRINCIPAL REGISTER

Feb 6, 2024 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Nov 21, 2023 NPUB

PUBLISHED FOR OPPOSITION

Nov 21, 2023 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Nov 1, 2023 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 19, 2023 CNSA

EXAMINER'S AMENDMENT ENTERED

Oct 12, 2023 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Oct 12, 2023 GNEN

EXAMINERS AMENDMENT E-MAILED

Oct 12, 2023 GNEA

EXAMINERS AMENDMENT -WRITTEN

Oct 12, 2023 CNEA

ASSIGNED TO EXAMINER

Sep 26, 2023 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 3, 2023 NWOS

NEW APPLICATION ENTERED

Jan 2, 2023 NWAP

Related Trademarks

More from this Owner

Serial #97735947

More in Same Class

HISTORY GROOMING COMPANY

WELLHEAL

ASANTE BODY MOVEMENT

BEND

NEXT CONVERSATION

REMEDY